Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Denaro

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Therapeutic Drug Monitoring|March 5, 1998
Evaluation of pharmacokinetic methods used to estimate caffeine clearance and comparison with a Bayesian forecasting methodC P Denaro, P Jacob, N L Benowitz
Australian and New Zealand Journal of Medicine|December 7, 2000
Kikuchi's disease associated with parotidomegaly, thyroiditis and a rash in a young manM A Keogh, R M Williamson, C P Denaro
Clinical Pharmacology and Therapeutics|March 1, 1996
Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearanceC P Denaro, M Wilson, P Jacob, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
The effect of liver disease on urine caffeine metabolite ratiosC P Denaro, M Wilson, P Jacob, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
Stable isotope method for studying transdermal drug absorption: the nicotine patchN L Benowitz, K Chan, C P Denaro, et al.
Internal Medicine Journal|June 1, 2012
Improving quality of delirium care in a general medical service with established interdisciplinary care: a controlled trialA M Mudge, C Maussen, J Duncan, et al.
AJNR. American Journal of Neuroradiology|July 1, 1991
MR imaging of reversible cyclosporin A-induced neurotoxicityC L Truwit, C P Denaro, J R Lake, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effects of caffeine with repeated dosingC P Denaro, C R Brown, P Jacob, et al.
Clinical Pharmacology and Therapeutics|January 1, 1993
Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effectsJ Shi, N L Benowitz, C P Denaro, et al.
The Medical Journal of Australia|September 8, 2001
Lipid-lowering therapy following major cardiac events: progress and deficitsA M Mudge, R Brockett, K F Foxcroft, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Therapeutic Drug Monitoring|March 5, 1998
Evaluation of pharmacokinetic methods used to estimate caffeine clearance and comparison with a Bayesian forecasting methodC P Denaro, P Jacob, N L Benowitz
Australian and New Zealand Journal of Medicine|December 7, 2000
Kikuchi's disease associated with parotidomegaly, thyroiditis and a rash in a young manM A Keogh, R M Williamson, C P Denaro
Clinical Pharmacology and Therapeutics|March 1, 1996
Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearanceC P Denaro, M Wilson, P Jacob, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
The effect of liver disease on urine caffeine metabolite ratiosC P Denaro, M Wilson, P Jacob, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
Stable isotope method for studying transdermal drug absorption: the nicotine patchN L Benowitz, K Chan, C P Denaro, et al.
Internal Medicine Journal|June 1, 2012
Improving quality of delirium care in a general medical service with established interdisciplinary care: a controlled trialA M Mudge, C Maussen, J Duncan, et al.
AJNR. American Journal of Neuroradiology|July 1, 1991
MR imaging of reversible cyclosporin A-induced neurotoxicityC L Truwit, C P Denaro, J R Lake, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effects of caffeine with repeated dosingC P Denaro, C R Brown, P Jacob, et al.
Clinical Pharmacology and Therapeutics|January 1, 1993
Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effectsJ Shi, N L Benowitz, C P Denaro, et al.
The Medical Journal of Australia|September 8, 2001
Lipid-lowering therapy following major cardiac events: progress and deficitsA M Mudge, R Brockett, K F Foxcroft, et al.
Pageof 3